Clinical Trial, Open-label, Randomised, in Order to Compare the Quality of Life for Those HIV+ Patients That Start With Monotherapy on LPV/r Tablets Vs. Triple Therapy With a Boosted Protease Inhibitor.

Trial Profile

Clinical Trial, Open-label, Randomised, in Order to Compare the Quality of Life for Those HIV+ Patients That Start With Monotherapy on LPV/r Tablets Vs. Triple Therapy With a Boosted Protease Inhibitor.

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 May 2013

At a glance

  • Drugs Lopinavir/ritonavir (Primary) ; Antiretrovirals; HIV protease inhibitors; Ritonavir
  • Indications HIV-1 infections
  • Focus Therapeutic Use
  • Acronyms QoLKAMON
  • Most Recent Events

    • 11 Jul 2011 Planned End Date changed from 1 Feb 2011 to 1 Dec 2011 as reported by ClinicalTrials.gov.
    • 11 Jul 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 05 Aug 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top